Premium
Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma
Author(s) -
Ryall R. D. H.,
Bates T.,
Newton K. A.,
Hellmann K.
Publication year - 1979
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197909)44:3<891::aid-cncr2820440315>3.0.co;2-r
Subject(s) - medicine , chondrosarcoma , radiation therapy , oncology , surgery
Eight patients with 12 chondrosarcomas were treated with radiation and razoxane (ICRF 159). Two tumors in 1 patient progressed unequivocally, 3 tumors in 3 patients showed no change, and 7 tumors in 5 patients had complete or partial (more than 50%) regressions. At least 2 complete regressions have responded for more than 2 1/2 years at the present time.